Core Technology

Any-Body

Monoclonal Antibodies with high specificity and affinity

BeyondDx utilizes its expertise in developing diagnostic-grade monoclonal antibodies to secure antibodies for various biomarkers, which are then incorporated into products. The development process involves selecting optimal antigens reflecting the state of the target marker within the blood, resulting in antibodies with high specificity and affinity. The final selected monoclonal antibodies are carefully screened and optimized for the platform to be utilized during the development process. Essential antibody pairs required for immunoassays are also swiftly screened using our in-house platform.